ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 733,50
0,31%
Dow Jones
43 487,83
0,78%
DAX
20 990,31
0,44%
Brent Oil
79,275
0,07%
Bitcoin
101 746,85
-0,27%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Proteonomix Inc (CE) (PROT) Cours

Proteonomix Inc (CE)

Proteonomix Inc (CE) (PROT)

USOTC
0,000001
0,00
(0,00%)
Fermé 21 Janvier 10:00PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,000001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,000001
Clôture Veille
0,000001
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
4 600
Volume financier
-
VWAP
-

PROT Dernières nouvelles

Plus de nouvelles

Proteonomix Settles Litigation

Proteonomix Settles Litigation PR Newswire PARAMUS, N.J., April 1, 2013 PARAMUS, N.J., April 1, 2013 /PRNewswire/ -- Proteonomix, Inc. (OTC: PROT), a biotechnology company focused on developing...

01 Avril 2013
PR Newswire (US)

Proteonomix Announces Extension Of Deadline

Proteonomix Announces Extension Of Deadline /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt...

14 Janvier 2013
PR Newswire (US)

Proteonomix To Require Physical Exchange Of Certificates

Proteonomix To Require Physical Exchange Of Certificates /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li {...

10 Janvier 2013
PR Newswire (US)

Proteonomix Announces Restructuring

Proteonomix Announces Restructuring /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-f...

08 Janvier 2013
PR Newswire (US)

Proteonomix Updates Status Of UMK-121 Testing

Proteonomix Updates Status Of UMK-121 Testing /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8...

08 Janvier 2013
PR Newswire (US)

Proteonomix, Inc. Announces Screening of Patients with End Stage Liver Disease in its Clinical Study of UMK-121

Proteonomix, Inc. Announces Screening of Patients with End Stage Liver Disease in its Clinical Study of UMK-121 /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; co...

20 Novembre 2012
PR Newswire (US)

Proteonomix, Inc. Announces Finalizing ECRF for Its Clinical Trial of UMK 121 in Patients with End Stage Liver Disease

Proteonomix, Inc. Announces Finalizing ECRF for Its Clinical Trial of UMK 121 in Patients with End Stage Liver Disease /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Ari...

26 Octobre 2012
PR Newswire (US)

Proteonomix, Inc. Announces Its Clinical Trial of UMK-121 in Patients with End Stage Liver Disease Has Been Listed on Clinica...

Proteonomix, Inc. Announces Its Clinical Trial of UMK-121 in Patients with End Stage Liver Disease Has Been Listed on ClinicalTrials.gov /* Style Definitions...

23 Octobre 2012
PR Newswire (US)

Proteonomix, Inc. Announces IRB Approval for Its Clinical Trial of UMK-121 in Patients with End Stage Liver Disease

Proteonomix, Inc. Announces IRB Approval for Its Clinical Trial of UMK-121 in Patients with End Stage Liver Disease PR Newswire PARAMUS, N.J., Oct. 4, 2012 PARAMUS, N.J., Oct. 4, 2012...

04 Octobre 2012
PR Newswire (US)

Proteonomix Announces Agreement with the University of Medicine & Dentistry of New Jersey (UMDNJ) to Conduct a Phase 1 Trial ...

Proteonomix, Inc. (OTC/BB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced it has...

14 Septembre 2012
Business Wire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
4001.0E-61.0E-61.0E-646001.0E-6CS
12001.0E-61.0E-61.0E-646001.0E-6CS
26001.0E-61.0E-61.0E-670001.0E-6CS
52001.0E-61.0E-61.0E-643751.0E-6CS
156001.0E-60.00011.0E-6303858.029E-5CS
260-0.014999-99.99333333330.0150.031.0E-6193410.00615471CS

PROT - Frequently Asked Questions (FAQ)

What is the current Proteonomix (CE) share price?
The current share price of Proteonomix (CE) is US$ 0,000001
What is the 1 year trading range for Proteonomix (CE) share price?
Proteonomix (CE) has traded in the range of US$ 0,000001 to US$ 0,000001 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19 900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18 600,00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0,0001
(9 900,00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9 900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9 900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
PROT
Proteonomix (CE)
TG
E2H
EPR Properties
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés